Azetidine → HCID 24856141, compound

HRID 2069507Notes

Reaction equation

HRID 2069507 reaction equation
[C:1]([C:5]1[N:6]=[C:7]([NH:10][C:11](=[O:25])[C:12]([S:15]([C:18]2[CH:19]=[N:20][C:21](Cl)=[CH:22][CH:23]=2)(=[O:17])=[O:16])([CH3:14])[CH3:13])[S:8][CH:9]=1)([CH3:4])([CH3:3])[CH3:2].C(=O)([O-])[O-].[K+].[K+].[NH:32]1[CH2:35][CH2:34][CH2:33]1>O1CCOCC1>[N:32]1([C:21]2[N:20]=[CH:19][C:18]([S:15]([C:12]([CH3:14])([CH3:13])[C:11]([NH:10][C:7]3[S:8][CH:9]=[C:5]([C:1]([CH3:4])([CH3:3])[CH3:2])[N:6]=3)=[O:25])(=[O:17])=[O:16])=[CH:23][CH:22]=2)[CH2:35][CH2:34][CH2:33]1

Participants

5

Conditions

Temperature
70 °C

Procedure

To a solution of 79 mg (0.20 mmol) of N-(4-tert-butyl-thiazol-2-yl)-2-(6-chloro-pyridine-3-sulfonyl)-2-methyl-propionamide (example 265, Table 19) and 57.5 mg (0.42 mmol) of potassium carbonate in dioxane (2 mL) were added 27 μL (0.4 mmol) of azetidine. The reaction was heated in a sealed tube to 70° C. for 3 h. The solids were removed by filtration and rinsed with dioxane (5 mL). The filtrate was concentrated under reduced pressure and the residue purified by column chromatography (silica, eluent DCM, 5-10% ethyl acetate) to afford 67 mg of 2-(6-azetidin-1-yl-pyridine-3-sulfonyl)-N-(4-tert-butyl-thiazol-2-yl)-2-methyl-propionamide.

Workup

  1. customThe solids were removed by filtration
  2. washrinsed with dioxane (5 mL)
  3. concentrationThe filtrate was concentrated under reduced pressure
  4. customthe residue purified by column chromatography (silica, eluent DCM, 5-10% ethyl acetate)

Sources & evidence

ORD record
ord-a7a443a35e0e424ca2a4c87d805c0e28
Source dataset
uspto-grants-2012_10
Patent number
US08299111B2

Reaction notes

Loading…